Literature DB >> 1083525

Distribution of Ia-like molecules on the surface of normal and leukemic human cells.

S F Schlossman, L Chess, R E Humphreys, J L Strominger.   

Abstract

Antiserum to a glycoprotein antigen complex of 23,000 and 30,000 dalton subunits (p23,30), isolated and purified from a human lymphoblastoid B cell line, was shown to be highly specific for human bursal-equivalent-processed (B) cells, reactive with 15-20% of human Null cells, but completely unreactive with human thymus-processed (T) cells. The p23,30 antigen is widely distributed on chronic lymphatic leukemic cells, 85% of acute lymphatic leukemic cells, all acute myelogenous leukemic cells, but not on chronic myelogenous leukemic cells. A rabbit antiserum specific for normal human thymocytes has also been prepared; it is reactive only with precisely that subset of acute lymphatic leukemic cells (15%) whose members do not have p23,30 on their surfaces.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1083525      PMCID: PMC430249          DOI: 10.1073/pnas.73.4.1288

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  16 in total

1.  Lymphocyte binding of aggregated IgG and surface Ig staining in chronic lymphocytic leukaemia.

Authors:  H B Dickler; F P Siegal; Z H Bentwich; H G Kunkel
Journal:  Clin Exp Immunol       Date:  1973-05       Impact factor: 4.330

2.  Immunologic functions of isolated human lymphocyte subpopulations. I. Quantitative isolation of human T and B cells and response to mitogens.

Authors:  L Chess; R P MacDermott; S F Schlossman
Journal:  J Immunol       Date:  1974-10       Impact factor: 5.422

3.  T cell surface markers on lymphoblasts from acute lymphocytic leukemia.

Authors:  L Borella; L Sen
Journal:  J Immunol       Date:  1973-10       Impact factor: 5.422

4.  Independent movement of IgD and IgM molecules on the surface of individual lymphocytes.

Authors:  W Knapp; R L Bolhuis; J Rádl; W Hijmans
Journal:  J Immunol       Date:  1973-10       Impact factor: 5.422

5.  Cell-surface immunoglobulins in chronic lymphocytic leukemia and allied disorders.

Authors:  A C Aisenberg; K J Bloch; J C Long
Journal:  Am J Med       Date:  1973-08       Impact factor: 4.965

6.  Leukemic cells with membrane properties of thymus-derived (T) lymphocytes in a case of Sézary's syndrome: morphologic and immunologic studies.

Authors:  J D Broome; D Zucker-Franklin; M S Weiner; C Bianco; V Nussenzweig
Journal:  Clin Immunol Immunopathol       Date:  1973-04

7.  Indications of the thymus-derived nature of the proliferating cells in six patients with Sézary's syndrome.

Authors:  J C Brouet; G Flandrin; M Seligmann
Journal:  N Engl J Med       Date:  1973-08-16       Impact factor: 91.245

8.  Expression of human T and B lymphocyte cell-surface markers on leukaemic cells.

Authors:  G Brown; M F Greaves; T A Lister; N Rapson; M Papamichael
Journal:  Lancet       Date:  1974-09-28       Impact factor: 79.321

9.  Immunoglobulin D as a lymphocyte receptor.

Authors:  D S Rowe; K Hug; L Forni; B Pernis
Journal:  J Exp Med       Date:  1973-10-01       Impact factor: 14.307

10.  Recognition by pregnancy serums of non-HL-A alloantigens selectively expressed on B lymphocytes.

Authors:  R J Winchester; P Wernet; H G Kunkel; B Dupont; C Jersild; S M Fu
Journal:  J Exp Med       Date:  1975-04-01       Impact factor: 14.307

View more
  73 in total

1.  Detection of small numbers of immature cells in the blood of healthy subjects.

Authors:  J Oertel; B Oertel; J Schleicher; D Huhn
Journal:  J Clin Pathol       Date:  1998-12       Impact factor: 3.411

2.  Use of stimulating capacity of mixed lymphocyte reaction (MLR-S) as a possible marker for the cell-origin of null-cell acute lymphoblastic leukaemia.

Authors:  T Han; J Minowada
Journal:  Immunology       Date:  1978-08       Impact factor: 7.397

3.  Recent progress in the immunological characterization of leukaemic cells.

Authors:  M F Greaves
Journal:  Blut       Date:  1977-05

4.  Human thymus cells: a study of rosette-forming capacity with unsensitized and sensitized erythrocytes of various species.

Authors:  T Han; P Diegelman; S Subramanian; J Minowada
Journal:  Immunology       Date:  1979-11       Impact factor: 7.397

5.  Subset derivation of T-cell acute lymphoblastic leukemia in man.

Authors:  E L Reinherz; L M Nadler; S E Sallan; S F Schlossman
Journal:  J Clin Invest       Date:  1979-08       Impact factor: 14.808

6.  Direct evidence for loss of human suppressor cells during active autoimmune disease.

Authors:  A J Strelkauskas; R T Callery; J McDowell; Y Borel; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

7.  T-cell nature of leukaemic cells in a case of Sézary's syndrome with 'null-cell' features.

Authors:  L Lauriola; P Musiani; A Carbone; M Bartolini; P Cianciulli; M Piantelli
Journal:  J Clin Pathol       Date:  1979-09       Impact factor: 3.411

8.  B cell origin of non-T cell acute lymphoblastic leukemia. A model for discrete stages of neoplastic and normal pre-B cell differentiation.

Authors:  L M Nadler; S J Korsmeyer; K C Anderson; A W Boyd; B Slaughenhoupt; E Park; J Jensen; F Coral; R J Mayer; S E Sallan
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

9.  Isolation and immunologic characterization of a human. B-lymphocyte-specific, cell surface antigen.

Authors:  R E Humphreys; J M McCune; L Chess; H C Herrman; D J Malenka; D L Mann; P Parham; S F Schlossman; J L Strominger
Journal:  J Exp Med       Date:  1976-07-01       Impact factor: 14.307

10.  Cell surface differentiation antigens of the malignant T cell in Sezary syndrome and mycosis fungoides.

Authors:  B F Haynes; P Bunn; D Mann; C Thomas; G S Eisenbarth; J Minna; A S Fauci
Journal:  J Clin Invest       Date:  1981-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.